Table 2 Changes in scores on the GCD Subscale for patients and partners
From: The measurement of response shift in patients with advanced prostate cancer and their partners
Months 0 – 3 |  |  | Months 3 – 6 |  |  |
|---|---|---|---|---|---|
Pre-test – Then-test ('Response Shift') (p*) | Patients (n = 53) | 1.0 (0.004) | Pre-test – Then-test ('Response Shift') (p*) | Patients (n = 53) | 1.6 (<0.001) |
|  | 95% C.I. | 0.4 – 1.7 |  | 95% C.I. | 1.0 – 2.2 |
| Â | Partners (n = 41) | 1.4 (0.001) | Â | Partners (n = 38) | 2.6 (<0.001) |
|  | 95% C.I. | 0.6 – 2.3 |  | 95% C.I. | 1.8 – 3.3 |
Pre-test – Post-test ('Traditional Change') (p*) | Patients (n = 53) | 1.2 (<0.001) | Pre-test – Post-test ('Traditional Change') (p*) | Patients (n = 53) | 0.6 (0.05) |
|  | 95% C.I. | 0.6 – 1.7 |  | 95% C.I. | 0.0 – 1.1 |
| Â | Partners (n = 41) | 1.3 (0.002) | Â | Partners (n = 38) | -0.7 (0.06) |
|  | 95% C.I. | 0.5 – 2.1 |  | 95% C.I. | -1.5 – 0.0 |
Then-test – Post-test ('Actual Change') (p*) | Patients (n = 53) | 2.2 (<0.001) | Then-test – Post-test ('Actual Change') (p*) | Patients (n = 53) | 2.2 (<0.001) |
|  | 95% C.I. | 1.6 – 2.8 |  | 95% C.I. | 1.6 – 2.8 |
| Â | Partners (n = 41) | 2.7 (<0.001) | Â | Partners (n = 38) | 1.8 (<0.001) |
|  | 95% C.I. | 2.0 – 3.4 |  | 95% C.I. | 1.0 – 2.6 |